Record Revenue, Pricing Lag — The Margin Recovery Bet

The headline reads like a blowout — and the revenue is genuine. But profit growth is only half of revenue growth. A ₹294.8 Cr result (up 53%) delivered ₹25 Cr PAT (up 21%), held down by a 290 basis point EBITDA margin collapse. Strip out the ₹6.06 Cr loss from the Mexico greenfield JV and adjusted PAT is ₹31.1 Cr — still solid, but the margin gap is the real story: polymer costs jumped 50%, customers absorbed only 7% in Q2, and the company is betting the remaining 43% flows through in Q3+. That's the bet that defines the next two quarters.

Knack's EBITDA margin fell to 16.35% from 19.25% YoY — a 290 basis point decline driven entirely by raw material inflation. Management disclosed that polypropylene costs rose over 50% in H1 due to Red Sea disruptions, but in Q2 only 7% of that increase was passed to customers. The remainder is captured as a pricing lag of 1–2 quarters. This is the crux: 45–50% of Knack's customer base sits on conversion-cost contracts (price-indexed, quarterly or monthly resets), which theoretically flow through immediately, but the practical lag means the company absorbed the margin hit upfront. The Mexico JV, in greenfield scale-up, dragged consolidated PAT by ₹6.06 Cr in Q2 — operational losses at 80–90 MT/month production against 400 MT installed capacity. Backing that out, underlying operational PAT is ₹31.1 Cr, a margin of 10.6% on ₹294.8 Cr — still down from prior-year organic levels, but closer to a run-rate that reflects pricing lag, not a structural cliff.

Three tangible shifts emerged, each moving the medium-term needle. The new export order is the marquee catalyst. In early October 2026, Knack announced a ₹150 Cr/month (₹1,800 Cr annualized) contract with an international pet-food/animal-nutrition corporation — one of the largest global players in that space. This is a 3-year minimum contract, providing multi-quarter revenue visibility and directly addressing the biggest investor question: how will the new 70k-ton Gujarat plant be absorbed? At current prices, this order alone represents 6–7% of anticipated FY27 revenue, and it materially lifts utilization assumptions. Pinch-bottom mix acceleration is outpacing prior guidance. Management targeted 23% mix expansion from the prior baseline; Knack has already achieved 21% revenue contribution in Q2 (up from 17–18% in FY26). With 5 machines online and 60–70% utilized, the ramp is credible and the margin tailwind (pinch-bottom commands premium pricing) is visible. Interim capacity bridge is live. In August 2026, Knack added 5,040 MT of rented interim capacity to bridge the gap until the new Gujarat plant commissioning in October 2027. Management is targeting 50% utilization (2,500 MT) by Q3 FY27, which would add ~₹40–50 Cr in annualized incremental revenue. This capacity is filling the new ₹150 Cr order and supporting export customer wins.

Knack's stock has sold off sharply since its all-time high of ₹222, now trading at ₹184.18 (down 17.04% from ATH). More tellingly, it sits below both the 20-day and 50-day moving averages (₹202.23 and ₹193.19 respectively), signaling sustained selling pressure despite the positive Q2 result. The market's skepticism is palpable: a record revenue print and a ₹150 Cr/month order announcement are not lifting the tape. The institutional positioning tells the story. FII ownership stands at just 1.21% and DII at 9.31%, with promoters holding 70.59% — one of the heaviest promoter-to-public ratios in the small-cap space. The lack of institutional interest suggests that despite operational catalysts, the market is pricing in execution risk on the margin recovery thesis. Bulk and block deals from mid-July 2026 show accumulation in the ₹209–217 range (quantcap, Yuga Stocks, QE Securities), but the stock has traded below that since, indicating those buyers are underwater. This is a classic disconnect: the fundamentals (record revenue, new order, capacity additions, margin recovery expected) point north, but the market is discounting the pricing lag as longer or deeper. The bearish read is that polymer pass-through will be slower or incomplete, forcing the company to absorb more of the margin hit than guided.

The number to track: EBITDA margin in Q3. If it recovers towards 18–19%, the bull thesis is intact. If it stays below 17%, recovery is delayed and the ₹150 Cr order upside is offset by structural cost pressure.